Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 12 . 9 . 2019 Press release Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis 10 . 24 . 2019 Press release Galderma Demonstrates Robust Aesthetic Innovation Pipeline with Initiation of Seven New Clinical Studies 10 . 24 . 2019 Press release Fort Worth’s Galderma, Maker of Cetaphil, Presents the 5th Annual Wonder Run 5K and Kids 1K to Benefit Children’s Skin Disease Foundation 10 . 21 . 2019 Press release Face Up To Rosacea: Galderma launches new campaign to empower and equip rosacea patients to discuss the true burden of their disease with a dermatologist 10 . 10 . 2019 Press release Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic Dermatitis 10 . 9 . 2019 Press release Galderma Announces Positive Phase 2 Results for its Proprietary Liquid Formulation of an Investigational Botulinum Toxin and Approval of New State-of-the-Art Manufacturing Facility 10 . 7 . 2019 Press release Galderma Receives FDA Approval for AKLIEF® (trifarotene) Cream, 0.005%, the First New Retinoid Molecule for the Treatment of Acne in Over 20 Years 10 . 2 . 2019 Press release Galderma to become the world’s largest independent global dermatology company after completion of CHF 10.2 billion carve-out of Nestlé Skin Health 6 . 11 . 2019 Press release Cetaphil® Announces Partnership with Award-Winning Actress, Rachel Brosnahan 6 . 11 . 2019 Press release Launch of the Skin Science Foundation 5 . 16 . 2019 Press release Nestlé enters into exclusive negotiations to sell Nestlé Skin Health to a consortium led by EQT and ADIA 4 . 30 . 2019 Press release A Decade of Dysport®: Galderma Celebrates 10 Years Since FDA Approval of Dysport in the U.S. Pagination Previous page Previous Page Next page Next Page